The University of Chicago Header Logo

Review of ranibizumab trials for neovascular age-related macular degeneration.

Review of ranibizumab trials for neovascular age-related macular degeneration. Semin Ophthalmol. 2011 Nov; 26(6):372-9.

View in: PubMed